http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA00008172-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_437e34b09a3abcb885ab5bdb7962385b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
| filingDate | 1999-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_987dc944263278356d25bd7781cefe07 |
| publicationDate | 2002-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-PA00008172-A |
| titleOfInvention | PHARMACOLOGICAL PREPARATION UNDERSTANDING A TYPE 2 RECEPTOR AGONIST OF ANGIOTENSIN II AND USING THE SAME. |
| abstract | A pharmaceutical preparation comprising an angiotensin I I type 2 receptor agonist, which may be either a peptide, or a mimetic agent of a peptide; This preparation is useful for the treatment and prophylaxis of eating tract disorders, such as dyspepsia, irritable bowel syndrome, and multiple organ failure. The use of an angiotensin I I type 2 receptor agonist, for the manufacture of a medicament for the treatment and / or prophylaxis of eating tract disorders, such as dyspepsia, irritable bowel syndrome, and multiple organ failure. A method for the treatment and / or prevention of a condition selected from the group consisting of disorders of the alimentary tract, such as dyspepsia, irritable bowel syndrome, and multiple organ failure in a patient, where an effective amount of a angiotensin II type 2 receptor agonist is administered to a patient. |
| priorityDate | 1998-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.